EV/EBITDA:
-8.19-0.10(-1.24%)Summary
- As of today (July 6, 2025), RARE EV/EBITDA is -8.19, with a fall of -0.10 (-1.24%) during the most recent trading session on July 3, 2025.
- Over the past year, RARE EV/EBITDA has dropped by -1.53 (-22.97%).
- RARE EV/EBITDA is now -154.35% below its all-time high of -3.22.
Performance
RARE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RARE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.2% | +1.2% | +1.1% |
| 1 m1 month | -9.9% | +9.9% | +9.6% |
| 3 m3 months | - | - | +13.6% |
| 6 m6 months | - | - | -3.8% |
| ytdytd | - | - | -5.1% |
| 1 y1 year | -23.0% | +13.6% | -0.8% |
| 5 y5 years | +55.1% | -24.9% | -53.6% |
RARE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.42 | -10.4% | -8.19 | at low |
| 3 m | 3-month | -6.83 | -19.9% | -8.19 | at low |
| 6 m | 6-month | -6.83 | -19.9% | -8.49 | +3.5% |
| 1 y | 1-year | -6.66 | -23.0% | -11.36 | +27.9% |
| 3 y | 3-year | -3.22 | -154.3% | -11.36 | +27.9% |
| 5 y | 5-year | -3.22 | -154.3% | -75.56 | +89.2% |
| alltime | all time | -3.22 | -154.3% | -75.56 | +89.2% |
RARE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.19(+66.5%) |
| 2022 | -4.92(-63.7%) |
| 2021 | -13.56(-77.9%) |
| 2020 | -61.40(+1054.1%) |
| 2019 | -5.32(-55.0%) |
| Date | Value |
|---|---|
| 2018 | -11.82(+89.7%) |
| 2017 | -6.23(-44.4%) |
| 2016 | -11.20(-61.6%) |
| 2015 | -29.16(+18.8%) |
| 2014 | -24.55 |
FAQ
- What is Ultragenyx Pharmaceutical EV/EBITDA?
- What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical EV/EBITDA year-on-year change?
What is Ultragenyx Pharmaceutical EV/EBITDA?
The current EV/EBITDA of RARE is -8.19
What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high EV/EBITDA is -3.22
What is Ultragenyx Pharmaceutical EV/EBITDA year-on-year change?
Over the past year, RARE EV/EBITDA has changed by -1.53 (-22.97%)